Journal of Clinical Oncology | 2024
Reply to S. Fuji / How could we further improve the gilteritinib maintenance after allogeneic hematopoietic cell transplantation in FLT3-mutated AML?
Levis M, Hamadani M, Horowitz M, Chen YB
PubMed
PMID: 39083722
Abstract
Related Articles
CIBMTR Study #: BMT1506